New 3D hair follicle model to accelerate cure for baldness

New 3D Hair Follicle Model to Accelerate Cure for Baldness
A simplified diagram of a real hair follicle structure.

Hair loss is a common disorder that affects many men and women due to aging or medical conditions. Current FDA-approved drugs can minimize further hair loss but are unable to regrow new hair. The Institute of Bioengineering and Nanotechnology (IBN) has recently engineered a new hair follicle model that could help discover new drugs for hair regeneration1.

IBN Executive Director Professor Jackie Y. Ying said, "We have applied our cell and expertise to create a hair follicle-like structure that is very similar to the native hair follicle. This model allows us to better understand the mechanisms that control the development and growth of hair follicles. We hope that our invention would lead to novel ways to treat hair loss, which affects millions of people worldwide."

The hair follicle is a regenerating organ that produces a new hair shaft during each growth cycle. This hair growth cycle is controlled by interactions between two main cell types: epithelial cells, which surround the hair shaft, and dermal papilla cells, which are at the base of the follicle bulb. A three-dimensional (3D) hair follicle model would therefore be useful for studying these to identify new treatments for male and female pattern baldness.

By applying a patented microfiber fabrication technology2 for engineering different cell types in three dimensions, the IBN research team was able to fabricate a 3D hair follicle model that mimics the size and cell arrangement of a real hair follicle. They achieved this by combining two types of , namely, dermal papilla cells and keratinocytes, an type, within a translucent fibrous matrix.

IBN Team Leader and Principal Research Scientist Dr Andrew Wan elaborated, "Measuring the diameter of a strand of hair, our hair follicle-like structure exhibits similar as real hair follicles. In our model, the hair cells are implanted into very fine and transparent fibers, which can be easily examined under the microscope unlike conventional models, making them ideal for drug testing applications."

The IBN researchers found that the cells in their -like structures switched on genes that are usually active during the hair growth stage, and when transplanted into mice, they could grow further into natural-looking hair structures.

If commercialized, this technology could be used by pharmaceutical companies in the drug discovery stage to screen potential promoters or inhibitors of hair formation. Consumer care companies would also be interested in this technology platform as it would allow them to screen the effectiveness of active ingredients in personal care products for hair growth.

Related Stories

New research provides clues on why hair turns gray

Jun 14, 2011

A new study by researchers at NYU Langone Medical Center has shown that, for the first time, Wnt signaling, already known to control many biological processes, between hair follicles and melanocyte stem cells can dictate ...

Recommended for you

The impact of bacteria in our guts

15 minutes ago

The word metabolism gets tossed around a lot, but it means much more than whether you can go back to the buffet for seconds without worrying about your waistline. In fact, metabolism is the set of biochemical ...

Stem cell therapies hold promise, but obstacles remain

36 minutes ago

(Medical Xpress)—In an article appearing online today in the journal Science, a group of researchers, including University of Rochester neurologist Steve Goldman, M.D., Ph.D., review the potential and ch ...

New hope in fight against muscular dystrophy

1 hour ago

Research at Stockholm's KTH Royal Institute of Technology offers hope to those who suffer from Duchenne muscular dystrophy, an incurable, debilitating disease that cuts young lives short.

Biologists reprogram skin cells to mimic rare disease

19 hours ago

Johns Hopkins stem cell biologists have found a way to reprogram a patient's skin cells into cells that mimic and display many biological features of a rare genetic disorder called familial dysautonomia. ...

User comments